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THIS study investigated the ability of Clostridium
difficile toxin B, isolated from the VPI 10463
strain, to induce fever and neutrophilia in rats.
Intravenous injection of toxin B (0.005-0.5 g/kg)
evoked a dose-dependent increase in body tem-
perature. The febrile response to 0.5 g/kg of the
toxin started in 2.5 h, peaked at 5 h, and subsided
fully within 24h. Toxin B also induced a dose-
dependent neutrophilia. Pretreatment with indo-
methacin (2 mg/kg, i.p.) did not affect the neu-
trophilia induced by toxin B, but significantly
reduced the febrile response measured 4 to 8h
after toxin B injection. Dexamethasone (0.5 mg/
kg) also markedly diminished the febrile
response induced by toxin B. These results show
that Clostridium difficile toxin B induced a
febrile response susceptible to inhibition by
dexamethasone and indomethacin. Furthermore,
they suggest that prostaglandins are not involved
in the neutrophilia caused by this toxin.
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Introduction
Fever is an important component of the acute-
phase response (APR), which is induced by exo-
genous pyrogens (bacterial products), and is
related to their ability to stimulate cytokine pro-
duction by host cells, e.g. macrophages, lympho-
cytes and endothelial cells. Many of these
cytokines, including interleukin (IL)-I, IL-6,
tumour necrosis factor-cz (TNF-z), interferons
(IFNs), IL-8 and macrophage inflammatory
protein-1 (MIP-1), generally known as endogen-
ous pyrogens (EPs), can induce fever when in-
jected into experimental animals and humans.1-5
It is likely that IL-1, IL-6, TNF-x and IFNs induce
fever by stimulating synthesis of prostaglandins
(PGs). On the other hand, fevers induced by
MIP-1 in rabbits and rats and IL-8 in rats are inde-
pendent of prostaglandin synthesis.
2-5 Another
important component of APR is neutrophilia,
which is also dependent on synthesis and release
of cytokines, including IL-Iz and [3, TNF-cz and
IL-6, IL-8, as well other inflammatory mediators
6 11 such as C5a and PGs (El, Ei, Fzcz).
Clostridium difficile, a Gram-positive anaerobic
bacillus, is a common cause of diarrhoea asso-
ciated with antibiotic therapy in elderly and
12 13 debilitated hospitalized patients. The linical
presentation of this infection is broad and ranges
from an asymptomatic carriage to an acute
abdomen and fulminant, life-threatening
colitis.14,15 Clinical symptoms of C. difficile colitis
are profuse and debilitating diarrhoea, abdominal
pain and distension. Furthermore, systemic
features may also be present, such as poly-
morphonuclear leukocytosis, nausea, anorexia,
malaise, dehydration and fever.
14 This last sign is
clinically relevant in pseudomembranous colitis
associated with the infection by C. difficile.
16-18
Also, it has been suggested that, in postoperative
patients who develop diarrhoea, the presence of
an unexplained fever or high whim blood-cell
count is an important clue to this.9
Although C. difficile is non-invasive, its toxins
seem to permeate the mucosal barrier since they
can induce an antibody response by the host.
i
To date, two C. difficile exotoxins have been
described, toxin A (TXA) and toxin B (TXB),
each encoded by distinct genes.
21-24 TXA causes
fluid accumulation associated with mucosal
damage in several animal models.25 In contrast,
26 28 TXB has no enterotoxic activity, but it is
1 000-fold more potent as a cytotoxin than is
26 27" TXA in tissue culture lines. However, both
toxins are potent proinflammatory agents that
cause erythematous and haemorrhagic lesions in
rabbit and guinea-pig skin.26’27 In addition, both
TXA and TXB induce release of cytokines from
human monocytes, polymorphonuclear neutro-
phils and cultured epithelial cells.29-31
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To our knowledge there is no experimental the appropriate vehicle only. The injection of
demonstration of the ability of toxins from C TXB was carried out between 09.00 and 10.00 h.
di2ficile to induce fever and neutrophilia,
although these signals occur with this infection. Leucocyte counts.. Six h after TXB injection,
Hence, the aim of this study was to investigate animals were anaesthetized with pentobarbitone
the pyrogenic activity and the ability to induce sodium (40 mg/kg, i.p.) and blood samples were
neutrophilia of the C. difficile toxin B, in rats. In taken from the abdominal aorta for determina-
addition, we also investigated the effect of anti- tion of total and differential cell counts. These
inflammatory drugs in TXB-induced fever and are reported as the number of neutrophils per
neutrophilia, ml of blood.
Materials and Methods Drugs: Indomethacin was a gift from Merck,
Sharp & Dohme, Brazil. Dexamethasone (Deca-
Animals.. Wistar rats weighing 180-200g were dronal(R)) was purchased from Prodrome, Brazil.
housed at 24 1C under a 12h light/dark
cycle (lights on at 06.00 h), and had free access Statistical analysis: For analysis of the rectal tem-
to water and food. perature data, the average baseline temperature
before any injection was calculated for each
Temperature measurements: Rectal temperature animal, and all subsequent temperatures were
was measured by inserting a thermistor probe expressed as changes from this average value. All
(Y.S.I. no. 402) 3 cm into the rectum. The values are reported as the mean S.E.M. The area
animals were held manually in their cages during under the curve was calculated for each animal
the temperature measurements. This procedure and expressed in arbitrary units as an index for
was performed at least twice on the day before the magnitude of the febrile response over the
the experiment to minimize stress-induced tem- period of measurements (fever index). The indi-
perature changes secondary to handling. On the vidual results were then combined to calculate the
day of the experiment, the basal temperature of group mean _+ S.E.M. and were analysed for
each animal was determined at least three times, statistical significance using one-way analysis of
at 30 min intervals, before any injection. Only variance, followed by Tukey’s test. The limit for
animals with basal temperatures between 36.8 the level of significance was set atp < 0.05.
and 37.6C were used. After the injection of the
TXB or saline, the temperature of the rats was Results measured up to 6 or 8 h, at 30 min intervals. The
experiments were conducted at the thermo- Figure 1 shows that i.v. injection of C. dijlficile
neutral zone for rats (28 ___
1C) between 08.00 TXB (0.005, 0.05 and 0.5 l.tk/kg) induced a dose-
and 19.00 h.32 dependent increase in body temperature. Similar
to saline, the dose of 0.005 btg/kg promoted no
Purification ofC. difficile toxin B: TXB was pur- change in body temperature, whereas the dose
ified to homogeneity from culture filtrate of C. of 0.05 lg/kg induced a small but not significant
difficile (VPI 10463 strain) as described pre- increase (0.19 0.10C, 5h). At the highest
viously. Briefly, it was purified by ammonium dose (0.5 btg/kg) the increase in body tem-
sulphate precipitation, ion-exchange chromato- perature started around 2.5 h, peaked at 5 h (0.97
graphy on DEAE-Sepharose CL-6B, and immu- ___
0.10C) and returned to basal levels after 24h
noaffinity chromatography. Homogeneity of TXB (-0.13 ___
0.03C). The fever index from this
was assessed by crossed immunoelectrophoresis curve is represented in the fight of Fig. 1 (saline,
and polyacrylamide gel electrophoresis.
2 0.29 0.48; TXB, 0.005 l.tg/kg, 1.10 ___
0.64; 0.05
l.tg/kg 2.49 0.41; and 0.5 l.tg/kg; 4.92 ___
0.81)
Experimental protocols: TXB was administered and the correlation between the fever response
intravenously (i.v.) via a tail vein at doses of and the doses of TXB was r 0.97. Further-
0.005, 0.05, 0.5 and 2.5 I.tg/kg in a volume of more, TXB also induced a dose-dependent
0.2 ml. The effects of steroidal and non-steroidal neutrophilia 6 h after injection, which was statist-
anti-inflammatory drugs on temperature re- ically significant at doses of 0.05 and 0.5 l.tg/kg
sponses to i.v. injection of TXB were investi- (saline, 1.3 _-+ 0.2; TXB, 0.005 btg/kg, 1.5 ___
0.4;
gated. Indomethacin (2 mg/kg) was given 0.05 bt/kg, 3.9 0.2; and 0.5 btg/kg, 5.9 _+ 0.6
intraperitoneally (i.p.) 30 min before the i.v. x 10 cells/ml; r 0.96; Fig. 2).
injection of TXB. Dexamethasone (0.5 mg/kg) Pretreatment of rats with dexamethasone (0.5
was administered subcutaneously (s.c.) I h mg/kg, s.c.) i h before TXB administration mark-
before TXB. Control animals were treated with edly attenuated the febrile response induced by
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FIG. 1. Dose-dependent increase in body temperature induced by i.v. injection of different doses of Clostridiurn difficile toxin B (TXB) in
rats. TXB was injected at the doses indicated and the control group received saline only. Panel A shows the time-course of the
increase in body temperature induced by different doses of TXB. The values represent means -I- S.E.M. of the changes in rectal tem-
perature. Panel B shows means ___
S.E.M. of fever index of the different thermal responses shown on panel A. *Significantly different
from control (p < 0.05).
Toxi. B  ll/k )
FIG. 2. Neutrophilia induced by i.v. injection of Clostridium diffi-
cile toxin B (TXB)in rats. TXB was injected at the doses indi-
cated 6 h before blood collection. Control groups received saline
only. Values are means -t- S.E.M. The number of animals per
group is indicated above each bar. *Significantly different from
control (p < 0.05).
this toxin (0.5 btg/kg, i.v.; Fig. 3). In the whole
time-course of that response there was no differ-
ence between this group and saline treated
animals. Indomethacin (2 mg/kg, i.p.) injected 30
min before the TXB significantly reduced the
febrile response measured between 4 and 8h
after TXB injection (Fig. 4), but did not alter the
neutrophilia (control, 5.9 ___
0.6; indomethacin
pretreated, 6.7 ___
0.8 x 104 cells/ml). The
mean fever index was significantly reduced from
6.62 ___
0.90 to 2.16 0.83 and from 6.46 ___
0.60 to 3.22 ___
0.46 by dexamethasone and indo-
methacin pretreatments, respectively.
The mortality in animals that received 0.5 l.tg/kg
of TXB was 10.5% within 8 h, and was not mod-
ified by pretreatment with indomethacin or dexa-
methasone. The injection of 2.5 l.tg/kg of TXB
(five times higher than the highest dose con-
sidered here) killed all animals within 4 h (n 4).
Discussion
This study shows that intravenous injection of
TXB from Clostridium difficile induces dose-
dependent increases in rectal temperature and
neutrophilia, thus mimicking two important com-
ponents of APR. To our knowledge this study
represents the first demonstration of the ability
of C. difficile toxins to induce fever.
Toxin B, at a dose of 2.5 btg/kg, induced 100%
mortality in rats within 4h of injection. A sig-
nificant level of mortality induced by TXB was
also found by Lyerly et al.,
27 where doses of 1 to
5 l.tg/animal of this toxin resulted in the death of
about 50% of infant mice. This mortality may
well be related to the ability of TXB to induce
release of cytokines, such as IL-la, IL-I, IL-6,
and TNF,29 which are key mediators of APR4
and septic shock.5 Also, TXB is cytotoxic for a
variety of cells, e.g. monocytes and colonic
mucosal epithelial cells,29’36 which also might
contribute to the mortality caused by this toxin.
In the present study, dexamethasone markedly
reduced TXB-induced fever. It is well known that
dexamethasone inhibits febrile responses to a
variety of pyrogenic stimuli, among them poly-
inosinic:polycytidilic acid, lipopolysaccharide from
Gram-negative bacteria, as well as different cyto-
kines.4’37 This synthetic glucocorticoid has a wide
range of activity and may exert its antipyretic
effects by reducing the synthesis and secretion of
pyrogenic cytokines and eicosanoids. It is well
described that glucocorticoids suppress the cyto-
kine or LPS-stimulated production of IL-18,
Mediators of Inflammation Vol 5 1996 1851 Cardoso et al.
1.5
1.0
0
FIG. 3. Effect of dexamethasone (DEXA) pretreatment on the increase in rectal temperature induced by i.v. injection of 0.5 pg/kg of
Clostridiurn difficile toxin B (TXB) in rats. DEXA or saline (control groups) was given h before TXB. The different treatments are indi-
cated in the figure. Panel A shows the time-course of the changes in body temperature for the different treatments. The values repre-
sent means ___
S.E.M. of the changes in rectal temperature. Panel B shows means ___
S.E.M. of fever index of the different thermal
responses shown on panel A. *Significantly different from saline + saline; and **from saline + TXB, (p < 0.05).
g
FIG. 4. Effect of indomethacin pretreatment on the increase in rectal temperature induced by i.v. injection of 0.5 txg/kg of Clostridium
difficile toxin B (TXB) in rats. Indomethacin or Tris.HCI buffer (control groups) was given 30 min before TXB. The different treatments
are indicated in the figure. Panel A shows the time-course of the changes in body temperature for the different treatments. The values
represent means ___
S.E.M. of the changes in rectal temperature. Panel B shows means ___
S.E.M. of fever index of the different
thermal responses shown on panel A. *Significantly different from Tris + saline; and from Tris + TXB (p < 0.05).
TNF,9 IL-6 and IL-8,
4 all of which are putative
mediators of the febrile response. Furthermore,
the inhibition of eicosanoid synthesis by gluco-
corticoids results from the inhibition of expres-
sion of the inducible cyclooxygenase isoenzyme
and of mobilization of membrane phospholipids
via synthesis of the phospholipase A2 inhibitory
41 42 lipocortins. Thus, the susceptibility of TXB-
induced fever to inhibition by dexamethasone
suggests that the mechanisms involved in this
response might not be different from those trig-
gered by other stimuli.
We have also demonstrated that indomethacin
inhibits the febrile response, but not the neu-
trophilia, induced by TXB. The anti-inflammatory
activities of non-steroidal anti-inflammatory drugs
have been formerly ascribed to their ability to
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block PGs synthesis.4 Nevertheless, besides their
ability to block cyclooxygenase, new insights into
their possible alternative mechanisms of action
have emerged. In this regard, the antipyretic
actions of indomethacin and sodium salicylate
have been linked to their ability to induce release
of arginine vasopressin (agP)44-46 which is con-
sidered an endogenous cryogen.47 Thus, we
cannot rule out either hypothesis when interpret-
ing our results.
Since indomethacin did not change the neu-
trophilia induced by TXB, it is unlikely that PGs
mediate this response. On the other hand Ulich
et all.7’8 demonstrated that the treatment of rats
with indomethacin abolishes the neutrophilia
induced by IL-I], suggesting the involvement of
eicosanoids in this response. Moreover, theseC. difficile toxin B.. fever and neutrophilia
investigators showed that stable analogues of
PGE1, PGE2 and PGF2a promote neutrophilia.
6 In
our hands indomethacin at the same dose sig-
nificantly reduced the neutrophilia induced by
endotoxin from E. coli (unpublished data).
The true importance of each endogenous
mediator to promote fever has been a point of
intense debate. Since PGs do not seem to
mediate TXB-induced neutrophilia, it is possible
that the efficacy of indomethacin to inhibit the
fever induced by this toxin may also involve
mechanisms unrelated to cyclooxygenase block-
ade, such as AVP release. Further studies are
needed to help clarify this point.
In conclusion, we report that the intravenous
injection of TXB from C difficile induced fever
in rats by a mechanism which was susceptible to
inhibition by both dexamethasone and indo-
methacin. On the other hand, the neutrophilia
induced by TXB was not inhibited by indo-
methacin. Therefore, TXB may be a useful tool
for the understanding of the febrile response, as
well as other events of APR.
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